Enhanced release of soluble urokinase receptor by endothelial cells in contact with peripheral blood cells
Authors:
- Satu MustjokiSMSatu Mustjoki
- Nicolai SideniusNSNicolai Sidenius
- Antti VaheriAVAntti Vaheri
- 12 December 2000
- journal article
- Published by Wiley in FEBS Letters
- Vol. 486 (3) , 237-242
Abstract
The urokinase receptor (uPAR) on the cell surface plays an important role in extracellular proteolysis, cell migration and adhesion. Soluble uPAR (suPAR) has been recently discovered in plasma, but its origin is unclear. Our results now demonstrate that both unstimulated blood mononuclear and endothelial cells can release suPAR and that the release is enhanced when either mononuclear cells or thrombocytes are cultured together with endothelial cells. Co‐culture without cell–cell contacts fails to enhance suPAR release. We also found suPAR fragments, known to be potent inducers of chemotaxis, in co‐culture growth medium samples. Taken together, our results suggest that normal plasma suPAR can be produced by endothelial and mononuclear cells and that suPAR release in cell–cell contacts may have a regulatory role in cell adhesion.Keywords
This publication has 22 references indexed in Scilit:
- Shedding and cleavage of the urokinase receptor (uPAR): identification and characterisation of uPAR fragments in vitro and in vivoFEBS Letters, 2000
- Domain 1 of the urokinase receptor (uPAR) is required for uPAR‐mediated cell binding to vitronectinFEBS Letters, 2000
- Soluble urokinase receptor released from human carcinoma cells: A plasma parameter for xenograft tumour studiesBritish Journal of Cancer, 1999
- The urokinase receptorFibrinolysis and Proteolysis, 1998
- A urokinase‐sensitive region of the human urokinase receptor is responsible for its chemotactic activityThe EMBO Journal, 1997
- Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase‐Type Plasminogen Activator Receptor, uPARStem Cells, 1997
- Regulation of Integrin Function by the Urokinase ReceptorScience, 1996
- A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.Journal of Clinical Investigation, 1993
- HMEC-1: Establishment of an Immortalized Human Microvascular Endothelial Cell LineJournal of Investigative Dermatology, 1992
- Directed Plasminogen Activation at the Surface of Normal and Malignant Cells1991